{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:45:40Z","timestamp":1794649540140,"version":"4.9.1"},"reference-count":24,"publisher":"American Chemical Society (ACS)","issue":"18","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA030199"],"award-info":[{"award-number":["P30CA030199"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA009523"],"award-info":[{"award-number":["T32CA009523"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM139795"],"award-info":[{"award-number":["T32GM139795"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["DGE-2038238"],"award-info":[{"award-number":["DGE-2038238"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"CDMRP\/Melanoma Research Program","doi-asserted-by":"publisher","award":["W81XWH2210841"],"award-info":[{"award-number":["W81XWH2210841"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rational optimization of molecular glue degraders (MGD) remains a challenging and lengthy process even after identification of a promising scaffold. Unlike proteolysis targeting chimeras (PROTAC), MGDs rely on induced protein\u2013protein interactions as opposed to direct binding in order to target a protein of interest for degradation. Here, we report the synthesis of MGDs targeting the transcription factor ZBTB11 guided by protein complex modeling. Exploration of structure\u2013activity-relationships yielded JWJ-01-306 with improved ZBTB11 degradation activity and potent antiproliferative effects against BRAF inhibitor-resistant melanoma cells. Our findings led to the discovery of a novel MGD that targets a previously undrugged transcription factor with the potential to address acquired resistance to cancer therapy.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c01352","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T16:29:06Z","timestamp":1757089746000},"page":"19287-19302","source":"Crossref","is-referenced-by-count":8,"title":["Synthesis and Structure\u2013Activity\nRelationships\nof CRBN-Recruiting ZBTB11 Molecular Glue Degraders"],"prefix":"10.1021","volume":"68","author":[{"given":"Jiewei","family":"Jiang","sequence":"first","affiliation":[{"name":"University of California San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan L.","family":"Tran","sequence":"additional","affiliation":[{"name":"University of California San Diego , , , ,","place":["La Jolla, California, United States, 92093"]},{"name":"Sanford Burnham Prebys Medical Discovery Institute , , , ,","place":["La Jolla, California, United States, 92037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Svendsen","sequence":"additional","affiliation":[{"name":"Sanford Burnham Prebys Medical Discovery Institute , , , ,","place":["La Jolla, California, United States, 92037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-9748","authenticated-orcid":true,"given":"Eric S.","family":"Wang","sequence":"additional","affiliation":[{"name":"Sanford Burnham Prebys Medical Discovery Institute , , , ,","place":["La Jolla, California, United States, 92037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4091-7617","authenticated-orcid":true,"given":"Fleur M.","family":"Ferguson","sequence":"additional","affiliation":[{"name":"University of California San Diego , , , ,","place":["La Jolla, California, United States, 92093"]},{"name":"University of California San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"issue":"9","key":"2026073102155133500_cit1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.chembiol.2017.05.024","article-title":"Targeted protein\ndegradation: from chemical biology\nto drug discovery","volume":"24","author":"Cromm","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"2026073102155133500_cit2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/acsmedchemlett.9b00597","article-title":"PROTAC Technology: Opportunities and Challenges","volume":"11","author":"Gao","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"3","key":"2026073102155133500_cit3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/acs.biochem.2c00245","article-title":"Molecular Glues:\nThe Adhesive Connecting Targeted Protein\nDegradation to the Clinic","volume":"62","author":"Sasso","year":"2023","journal-title":"Biochemistry"},{"issue":"1","key":"2026073102155133500_cit4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41589-019-0411-6","article-title":"Structural basis of indisulam-mediated RBM39 recruitment to DCAF15\nE3 ligase complex","volume":"16","author":"Bussiere","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"2026073102155133500_cit5","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.25.576086","article-title":"A small molecule\nVHL molecular glue\ndegrader for cysteine dioxygenase 1","author":"Tutter","year":"2024","journal-title":"bioRxiv"},{"issue":"6414","key":"2026073102155133500_cit6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat0572","article-title":"Defining\nthe human\nC2H2 zinc finger degrome targeted by thalidomide analogs through CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science"},{"issue":"5971","key":"2026073102155133500_cit7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a\nprimary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"issue":"6168","key":"2026073102155133500_cit8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes\nselective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2014","journal-title":"Science"},{"issue":"6","key":"2026073102155133500_cit9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41589-021-00802-w","article-title":"Acute pharmacological\ndegradation of Helios destabilizes regulatory T cells","volume":"17","author":"Wang","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"2026073102155133500_cit10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.chembiol.2023.02.005","article-title":"Discovery and characterization of\na selective IKZF2 glue degrader for cancer immunotherapy","volume":"30","author":"Bonazzi","year":"2023","journal-title":"Cell Chem. Biol."},{"issue":"6704","key":"2026073102155133500_cit11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.adk6129","article-title":"A molecular glue\ndegrader of the WIZ transcription factor for fetal hemoglobin induction","volume":"385","author":"Ting","year":"2024","journal-title":"Science"},{"issue":"22","key":"2026073102155133500_cit12","doi-asserted-by":"publisher","first-page":"20682","DOI":"10.1021\/acs.jmedchem.4c02251","article-title":"Discovery and optimization\nof first-in-class molecular glue degraders of the WIZ transcription\nfactor for fetal hemoglobin induction to treat sickle cell disease","volume":"67","author":"Kerrigan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026073102155133500_cit13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19205-x","article-title":"Intellectual\ndisability-associated\nfactor Zbtb11 cooperates with NRF-2\/GABP to control mitochondrial\nfunction","volume":"11","author":"Wilson","year":"2020","journal-title":"Nat. Commun."},{"key":"2026073102155133500_cit14","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.19.594824","article-title":"ZBTB11 depletion\ntargets metabolic vulnerabilities\nin K-Ras inhibitor resistant PDAC","author":"Tran","year":"2024","journal-title":"bioRxiv"},{"issue":"10","key":"2026073102155133500_cit15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic\nassociations of oncogenic\nBRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"2026073102155133500_cit16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated\nBRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"2026073102155133500_cit17","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival\nwith vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2026073102155133500_cit18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined\ndabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"2026073102155133500_cit19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative\nmetabolism via PGC1alpha and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"2026073102155133500_cit20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance\nin melanoma by blocking the mitochondrial respiratory chain of slow-cycling\nJARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"issue":"7873","key":"2026073102155133500_cit21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein\nstructure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"1","key":"2026073102155133500_cit22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58431-z","article-title":"Development of PVTX-405 as a potent\nand highly selective molecular glue degrader of IKZF2 for cancer immunotherapy","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"issue":"24","key":"2026073102155133500_cit23","doi-asserted-by":"publisher","first-page":"16953","DOI":"10.1021\/acs.jmedchem.3c01736","article-title":"Design and development of IKZF2 and\nCK1alpha dual degraders","volume":"66","author":"Miyamoto","year":"2023","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026073102155133500_cit24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.chembiol.2023.02.005","article-title":"Discovery and characterization of\na selective IKZF2 glue degrader for cancer immunotherapy","volume":"30","author":"Bonazzi","year":"2023","journal-title":"Cell Chem. Biol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c01352","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19287\/66295725\/acs.jmedchem.5c01352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19287\/66295725\/acs.jmedchem.5c01352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:15:59Z","timestamp":1785478559000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/18\/19287\/5234834\/Synthesis-and-Structure-Activity-Relationships-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":24,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9,5]]},"published-print":{"date-parts":[[2025,9,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01352","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01352.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01352.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01352.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01352.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01352.s006","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}